{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:15:27Z","timestamp":1788347727585,"version":"build-2803163510"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:00:00Z","timestamp":1622073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012644","name":"Friends of FSH Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012644","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004243","name":"Prinses Beatrix Spierfonds","doi-asserted-by":"publisher","award":["W.OP14-01"],"award-info":[{"award-number":["W.OP14-01"]}],"id":[{"id":"10.13039\/501100004243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004243","name":"Prinses Beatrix Spierfonds","doi-asserted-by":"publisher","award":["W.OR21-04"],"award-info":[{"award-number":["W.OR21-04"]}],"id":[{"id":"10.13039\/501100004243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.omtn.2021.05.020","type":"journal-article","created":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T23:23:19Z","timestamp":1622503399000},"page":"342-354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Adenine base editing of the DUX4 polyadenylation signal for targeted genetic therapy in facioscapulohumeral muscular dystrophy"],"prefix":"10.1016","volume":"25","author":[{"given":"Darina","family":"\u0160ikrov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlad A.","family":"Cadar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yavuz","family":"Ariyurek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen F.J.","family":"Laros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Balog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silv\u00e8re M.","family":"van der Maarel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2021.05.020_bib1","doi-asserted-by":"crossref","first-page":"e444","DOI":"10.1212\/WNL.0000000000005915","article-title":"A family-based study into penetrance in facioscapulohumeral muscular dystrophy type 1","volume":"91","author":"Wohlgemuth","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.omtn.2021.05.020_bib2","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/hmg\/4.5.951","article-title":"Correlation between fragment size at D4F104S1 and age at onset or at wheelchair use, with a possible generational effect, accounts for much phenotypic variation in 4q35-facioscapulohumeral muscular dystrophy (FSHD)","volume":"4","author":"Lunt","year":"1995","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2021.05.020_bib3","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1212\/WNL.0000000000002217","article-title":"Milder phenotype in facioscapulohumeral dystrophy with 7-10 residual D4Z4 repeats","volume":"85","author":"Statland","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.omtn.2021.05.020_bib4","doi-asserted-by":"crossref","first-page":"e1001181","DOI":"10.1371\/journal.pgen.1001181","article-title":"Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene","volume":"6","author":"Snider","year":"2010","journal-title":"PLoS Genet."},{"key":"10.1016\/j.omtn.2021.05.020_bib5","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jid.2016.01.027","article-title":"DUX4 Is Derepressed in Late-Differentiating Keratinocytes in Conjunction with Loss of H3K9me3 Epigenetic Repression","volume":"136","author":"Gannon","year":"2016","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.omtn.2021.05.020_bib6","doi-asserted-by":"crossref","first-page":"e0160022","DOI":"10.1371\/journal.pone.0160022","article-title":"Influence of Repressive Histone and DNA Methylation upon D4Z4 Transcription in Non-Myogenic Cells","volume":"11","author":"Das","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2021.05.020_bib7","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/ng.3858","article-title":"DUX-family transcription factors regulate zygotic genome activation in placental mammals","volume":"49","author":"De Iaco","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2021.05.020_bib8","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/ng.3844","article-title":"Conserved roles of mouse DUX and human DUX4 in activating cleavage-stage genes and MERVL\/HERVL retrotransposons","volume":"49","author":"Hendrickson","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2021.05.020_bib9","doi-asserted-by":"crossref","first-page":"e1003947","DOI":"10.1371\/journal.pgen.1003947","article-title":"DUX4 binding to retroelements creates promoters that are active in FSHD muscle and testis","volume":"9","author":"Young","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.omtn.2021.05.020_bib10","doi-asserted-by":"crossref","first-page":"16957","DOI":"10.1038\/s41598-018-35150-8","article-title":"Low level DUX4 expression disrupts myogenesis through deregulation of myogenic gene expression","volume":"8","author":"Bosnakovski","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2021.05.020_bib11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.devcel.2011.11.013","article-title":"DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy","volume":"22","author":"Geng","year":"2012","journal-title":"Dev. Cell"},{"key":"10.1016\/j.omtn.2021.05.020_bib12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2044-5040-4-12","article-title":"Facioscapulohumeral dystrophy: the path to consensus on pathophysiology","volume":"4","author":"Tawil","year":"2014","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.omtn.2021.05.020_bib13","doi-asserted-by":"crossref","first-page":"e2273","DOI":"10.1212\/WNL.0000000000007456","article-title":"FSHD1 and FSHD2 form a disease continuum","volume":"92","author":"Sacconi","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.omtn.2021.05.020_bib14","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ajhg.2013.08.004","article-title":"The FSHD2 gene SMCHD1 is a modifier of disease severity in families affected by FSHD1","volume":"93","author":"Sacconi","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtn.2021.05.020_bib15","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/hmg\/2.12.2037","article-title":"FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit","volume":"2","author":"van Deutekom","year":"1993","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2021.05.020_bib16","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.ajhg.2016.03.013","article-title":"Mutations in DNMT3B Modify Epigenetic Repression of the D4Z4 Repeat and the Penetrance of Facioscapulohumeral Dystrophy","volume":"98","author":"van den Boogaard","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtn.2021.05.020_bib17","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ng.2454","article-title":"Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2","volume":"44","author":"Lemmers","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2021.05.020_bib18","doi-asserted-by":"crossref","first-page":"e2441","DOI":"10.1212\/WNL.0000000000009617","article-title":"Homozygous nonsense variant in LRIF1 associated with facioscapulohumeral muscular dystrophy","volume":"94","author":"Hamanaka","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.omtn.2021.05.020_bib19","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ng.142","article-title":"SmcHD1, containing a structural-maintenance-of- chromosomes hinge domain, has a critical role in X inactivation","volume":"40","author":"Blewitt","year":"2008","journal-title":"Nat. Genet"},{"key":"10.1016\/j.omtn.2021.05.020_bib20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.devcel.2012.06.011","article-title":"Smchd1-dependent and -independent pathways determine developmental dynamics of CpG island methylation on the inactive X chromosome","volume":"23","author":"Gendrel","year":"2012","journal-title":"Dev. Cell"},{"key":"10.1016\/j.omtn.2021.05.020_bib21","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1128\/MCB.00145-13","article-title":"Epigenetic functions of smchd1 repress gene clusters on the inactive X chromosome and on autosomes","volume":"33","author":"Gendrel","year":"2013","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.omtn.2021.05.020_bib22","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nsmb.2532","article-title":"Human inactive X chromosome is compacted through a PRC2-independent SMCHD1-HBiX1 pathway","volume":"20","author":"Nozawa","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.omtn.2021.05.020_bib23","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1128\/MCB.00432-15","article-title":"Independent Mechanisms Target SMCHD1 to Trimethylated Histone H3 Lysine 9-Modified Chromatin and the Inactive X Chromosome","volume":"35","author":"Brideau","year":"2015","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.omtn.2021.05.020_bib24","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1006\/geno.2002.6690","article-title":"Genomic analysis of human chromosome 10q and 4q telomeres suggests a common origin","volume":"79","author":"van Geel","year":"2002","journal-title":"Genomics"},{"key":"10.1016\/j.omtn.2021.05.020_bib25","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1086\/521986","article-title":"Specific sequence variations within the 4q35 region are associated with facioscapulohumeral muscular dystrophy","volume":"81","author":"Lemmers","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtn.2021.05.020_bib26","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ng999","article-title":"Facioscapulohumeral muscular dystrophy is uniquely associated with one of the two variants of the 4q subtelomere","volume":"32","author":"Lemmers","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2021.05.020_bib27","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1189044","article-title":"A unifying genetic model for facioscapulohumeral muscular dystrophy","volume":"329","author":"Lemmers","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.omtn.2021.05.020_bib28","series-title":"Chromosome 10q-linked FSHD identifies DUX4 as principal disease gene. J. Med. Genet","author":"Lemmers","year":"2021"},{"key":"10.1016\/j.omtn.2021.05.020_bib29","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1038\/mt.2016.111","article-title":"Morpholino-mediated Knockdown of DUX4 Toward Facioscapulohumeral Muscular Dystrophy Therapeutics","volume":"24","author":"Chen","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2021.05.020_bib30","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3390\/genes8030093","article-title":"Antisense Oligonucleotides Used to Target the DUX4 mRNA as Therapeutic Approaches in FaciosScapuloHumeral Muscular Dystrophy (FSHD)","volume":"8","author":"Ansseau","year":"2017","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.omtn.2021.05.020_bib31","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1093\/hmg\/ddw015","article-title":"Antisense targeting of 3\u2032 end elements involved in DUX4 mRNA processing is an efficient therapeutic strategy for facioscapulohumeral dystrophy: a new gene-silencing approach","volume":"25","author":"Marsollier","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2021.05.020_bib32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/jpm11010007","article-title":"Gene Editing Targeting the DUX4 Polyadenylation Signal: A Therapy for FSHD?","volume":"11","author":"Joubert","year":"2020","journal-title":"J.\u00a0Pers. Med."},{"key":"10.1016\/j.omtn.2021.05.020_bib33","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.omtn.2020.12.004","article-title":"Designed U7 snRNAs inhibit DUX4 expression and improve FSHD-associated outcomes in DUX4 overexpressing cells and FSHD patient myotubes","volume":"23","author":"Rashnonejad","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2021.05.020_bib34","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1158\/2159-8290.CD-16-0154","article-title":"Genomic copy number dictates a gene-independent cell response to CRISPR\/Cas9 targeting","volume":"6","author":"Aguirre","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.omtn.2021.05.020_bib35","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of A\u2022T to G\u2022C in genomic DNA without DNA cleavage","volume":"551","author":"Gaudelli","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2021.05.020_bib36","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.ymthe.2020.01.005","article-title":"Treatment of a Mouse Model of ALS by In\u00a0Vivo Base Editing","volume":"28","author":"Lim","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2021.05.020_bib37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41551-019-0501-5","article-title":"Cytosine and adenine base editing of the brain, liver, retina, heart and skeletal muscle of mice via adeno-associated viruses","volume":"4","author":"Levy","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.omtn.2021.05.020_bib38","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nbt.4148","article-title":"Adenine base editing in mouse embryos and an adult mouse model of Duchenne muscular dystrophy","volume":"36","author":"Ryu","year":"2018","journal-title":"Nat. Biotechnol"},{"key":"10.1016\/j.omtn.2021.05.020_bib39","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1089\/crispr.2018.0014","article-title":"EditR: A Method to Quantify Base Editing from Sanger Sequencing","volume":"1","author":"Kluesner","year":"2018","journal-title":"CRISPR J."},{"key":"10.1016\/j.omtn.2021.05.020_bib40","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nbt.4172","article-title":"Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction","volume":"36","author":"Koblan","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2021.05.020_bib41","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/hmg\/ddu486","article-title":"Inter-individual differences in CpG methylation at D4Z4 correlate with clinical variability in FSHD1 and FSHD2","volume":"24","author":"Lemmers","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2021.05.020_bib42","doi-asserted-by":"crossref","first-page":"21648","DOI":"10.1038\/s41598-020-78578-7","article-title":"Large genotype-phenotype study in carriers of D4Z4 borderline alleles provides guidance for facioscapulohumeral muscular dystrophy diagnosis","volume":"10","author":"Ricci","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2021.05.020_bib43","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41431-017-0015-0","article-title":"Deep characterization of a common D4Z4 variant identifies biallelic DUX4 expression as a modifier for disease penetrance in FSHD2","volume":"26","author":"Lemmers","year":"2018","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.omtn.2021.05.020_bib44","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.1093\/hmg\/ddu251","article-title":"DUX4-induced gene expression is the major molecular signature in FSHD skeletal muscle","volume":"23","author":"Yao","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2021.05.020_bib45","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1080\/15592294.2015.1113798","article-title":"Increased DUX4 expression during muscle differentiation correlates with decreased SMCHD1 protein levels at D4Z4","volume":"10","author":"Balog","year":"2015","journal-title":"Epigenetics"},{"key":"10.1016\/j.omtn.2021.05.020_bib46","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.nurt.2008.07.005","article-title":"Facioscapulohumeral muscular dystrophy","volume":"5","author":"Tawil","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.omtn.2021.05.020_bib47","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0168-9525(02)02709-9","article-title":"Metastable epialleles in mammals","volume":"18","author":"Rakyan","year":"2002","journal-title":"Trends Genet."},{"issue":"W1","key":"10.1016\/j.omtn.2021.05.020_bib48","doi-asserted-by":"crossref","first-page":"W242","DOI":"10.1093\/nar\/gky354","article-title":"CRISPOR: intuitive guide selection for CRISPR\/Cas9 genome editing experiments and screens","volume":"46","author":"Concordet","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2021.05.020_bib49","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","article-title":"CRISPResso2 provides accurate and rapid genome editing sequence analysis","volume":"37","author":"Clement","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2021.05.020_bib50","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.omtn.2021.05.020_bib51","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.molmed.2020.09.008","article-title":"Therapeutic Approaches in Facioscapulohumeral Muscular Dystrophy","volume":"27","author":"Cohen","year":"2021","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.omtn.2021.05.020_bib52","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/WCO.0000000000000849","article-title":"The prospects of targeting DUX4 in facioscapulohumeral muscular dystrophy","volume":"33","author":"Bouwman","year":"2020","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.omtn.2021.05.020_bib53","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.omtm.2020.12.001","article-title":"Targeted epigenetic repression by CRISPR\/dSaCas9 suppresses pathogenic DUX4-fl expression in FSHD","volume":"20","author":"Himeda","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2021.05.020_bib54","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41587-019-0134-y","article-title":"Circularly permuted and PAM-modified Cas9 variants broaden the targeting scope of base editors","volume":"37","author":"Huang","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2021.05.020_bib55","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/s41587-020-0453-z","article-title":"Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity","volume":"38","author":"Richter","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2021.05.020_bib56","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41556-020-0471-6","article-title":"Programmable base editing of mutated TERT promoter inhibits brain tumour growth","volume":"22","author":"Li","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.omtn.2021.05.020_bib57","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41586-020-03086-7","article-title":"In\u00a0vivo base editing rescues Hutchinson-Gilford progeria syndrome in mice","volume":"589","author":"Koblan","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2021.05.020_bib58","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.molcel.2017.02.007","article-title":"Crystal Structure of the Minimal Cas9 from Campylobacter jejuni Reveals the Molecular Diversity in the CRISPR-Cas9 Systems","volume":"65","author":"Yamada","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omtn.2021.05.020_bib59","doi-asserted-by":"crossref","first-page":"14500","DOI":"10.1038\/ncomms14500","article-title":"In\u00a0vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni","volume":"8","author":"Kim","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2021.05.020_bib60","doi-asserted-by":"crossref","first-page":"998","DOI":"10.3389\/fgene.2020.00998","article-title":"The Crosstalk Between Epigenetic Mechanisms and Alternative RNA Processing Regulation","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.omtn.2021.05.020_bib61","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.molcel.2020.03.024","article-title":"DNA Methylation Regulates Alternative Polyadenylation via CTCF and the Cohesin Complex","volume":"78","author":"Nanavaty","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omtn.2021.05.020_bib62","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41392-019-0044-y","article-title":"Off-Targeting of Base Editors: BE3 but not ABE induces substantial off-target single nucleotide variants","volume":"4","author":"Xin","year":"2019","journal-title":"Signal Transduct Target. Ther"},{"key":"10.1016\/j.omtn.2021.05.020_bib63","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41586-019-1161-z","article-title":"Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors","volume":"569","author":"Gr\u00fcnewald","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2021.05.020_bib64","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/s41587-019-0236-6","article-title":"CRISPR DNA base editors with reduced RNA off-target and self-editing activities","volume":"37","author":"Gr\u00fcnewald","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2021.05.020_bib65","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41586-019-1314-0","article-title":"Off-target RNA mutation induced by DNA base editing and its elimination by mutagenesis","volume":"571","author":"Zhou","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2021.05.020_bib66","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1038\/s41467-018-05477-x","article-title":"Directed evolution of CRISPR-Cas9 to increase its specificity","volume":"9","author":"Lee","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2021.05.020_bib67","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nature16526","article-title":"High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects","volume":"529","author":"Kleinstiver","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2021.05.020_bib68","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.aad5227","article-title":"Rationally engineered Cas9 nucleases with improved specificity","volume":"351","author":"Slaymaker","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.omtn.2021.05.020_bib69","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/nar\/gkx1199","article-title":"Improving CRISPR-Cas specificity with chemical modifications in single-guide RNAs","volume":"46","author":"Ryan","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2021.05.020_bib70","doi-asserted-by":"crossref","first-page":"15790","DOI":"10.1038\/ncomms15790","article-title":"Improving the DNA specificity and applicability of base editing through protein engineering and protein delivery","volume":"8","author":"Rees","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2021.05.020_bib71","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.molcel.2017.08.008","article-title":"CRISPR-Mediated Base Editing Enables Efficient Disruption of Eukaryotic Genes through Induction of STOP Codons","volume":"67","author":"Billon","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omtn.2021.05.020_bib72","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nmeth.4327","article-title":"CRISPR-STOP: gene silencing through base-editing-induced nonsense mutations","volume":"14","author":"Kuscu","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtn.2021.05.020_bib73","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ymthe.2019.11.022","article-title":"Efficient Gene Silencing by Adenine Base Editor-Mediated Start Codon Mutation","volume":"28","author":"Wang","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2021.05.020_bib74","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/nph.15647","article-title":"Gene disruption through base editing-induced messenger RNA missplicing in plants","volume":"222","author":"Li","year":"2019","journal-title":"New Phytol."},{"key":"10.1016\/j.omtn.2021.05.020_bib75","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13059-018-1482-5","article-title":"CRISPR-SKIP: programmable gene splicing with single base editors","volume":"19","author":"Gapinske","year":"2018","journal-title":"Genome Biol."},{"key":"10.1016\/j.omtn.2021.05.020_bib76","doi-asserted-by":"crossref","first-page":"5799","DOI":"10.1093\/nar\/18.19.5799","article-title":"Point mutations in AAUAAA and the poly (A) addition site: effects on the accuracy and efficiency of cleavage and polyadenylation in\u00a0vitro","volume":"18","author":"Sheets","year":"1990","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2021.05.020_bib77","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/emboj.2010.42","article-title":"A functional human Poly(A) site requires only a potent DSE and an A-rich upstream sequence","volume":"29","author":"Nunes","year":"2010","journal-title":"EMBO J."},{"key":"10.1016\/j.omtn.2021.05.020_bib78","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1101\/gr.10.7.1001","article-title":"Patterns of variant polyadenylation signal usage in human genes","volume":"10","author":"Beaudoing","year":"2000","journal-title":"Genome Res."},{"key":"10.1016\/j.omtn.2021.05.020_bib79","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.omtn.2021.05.020_bib80","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1474-9726.2007.00306.x","article-title":"Cellular senescence in human myoblasts is overcome by human telomerase reverse transcriptase and cyclin-dependent kinase 4: consequences in aging muscle and therapeutic strategies for muscular dystrophies","volume":"6","author":"Zhu","year":"2007","journal-title":"Aging Cell"}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253121001360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253121001360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T01:29:57Z","timestamp":1761874197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253121001360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":80,"alternative-id":["S2162253121001360"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2021.05.020","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adenine base editing of the DUX4 polyadenylation signal for targeted genetic therapy in facioscapulohumeral muscular dystrophy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2021.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s).","name":"copyright","label":"Copyright"}]}}